The ups and downs of adenovirus vectors

Bulletin of the New York Academy of Medicine: Journal of Urban Health

Volumn 73, Issue 1, 1996, Pages 53-58

  Ginsberg, Harold S ^a,b  

^a Columbia University ^*  (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA; VIRUS PROTEIN; VIRUS VACCINE;

ADENOVIRUS; ANIMAL; GENE EXPRESSION REGULATION; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; IMMUNIZATION; IMMUNOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; REVIEW; T LYMPHOCYTE; VIRION; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ADENOVIRUS E3 PROTEINS; ANIMALS; DNA, VIRAL; GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; GENETIC VECTORS; GENOME, VIRAL; GLYCOPROTEINS; HUMANS; IMMUNIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; VIRAL VACCINES; VIRION; VIRUS REPLICATION;

EID: 0030161789     PISSN: 00287091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Rowe WP, Huebner RJ, Gilmore RJ, Parrott RN, Ward TG. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med. 1953;84:570-573.
2. Hilleman MR, Werner JR. Recovery of new agent from patients with acute respiratory illness. Proc Soc Exp Biol Med. 1954;85:183-188.
3. Hierholzer JC, Wigand W, Anderson LJ, Adrian T, Gold JW. Adenoviruses from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D (types 43-47). J Infect Dis. 1988;158:804-813.
4. Ginsberg HS. Adenoviruses. In Microbiology. 4th Edition. Davis BD, Dulbecco R, Eisen HN, Ginsberg HS, eds. Philadelphia: Lippincott, 1990, pp. 915-928 (Chap. 52).
5. Dulbecco R. Viral immunology. In Microbiology. 4th Edition. Davis BD, Dulbecco R, Eisen HN, Ginsberg HS, eds. Philadelphia: Lippincott, 1990, pp. 885-898 (Chap. 50).
6. Shenk, T. Adenoviridae: the viruses and their replication. In Virology, 3rd Edition. Fields BN, Knipe DM, Howley PM, eds. Philadelphia: Lippincott-Raven, 1996, pp. 2111-2148 (Chap. 67).
7. Burgert HG, Kvist S. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatability class I antigens. Cell. 1985;41:987-997.
8. Andersson M, Paabo S, Nilsson T, Peterson PA. Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell. 1985;43:215-222.
9. Ginsberg HS, Lundholm-Beauchamp U, Horswood RI, et al. Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc Natl Acad Sci USA. 1989;86:3823-3827.
10. Rosenfeld MA, Yoshimura K, Trapnell BC, et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell. 1992;68:143-155.
11. Prince GA, Porter DD, Jenson AB, et al. Pathogenesis of adenovirus type 5 pneumonia in cotton rats. J Virol. 1993;67:101-111.
12. Ginsberg HS, Prince GA. The molecular basis of adenovirus pathogenesis. Infectious Agents and Disease. 1994;3:1-8.
13. Ginsberg HS, Moldawer LL, Sehgal PR, et al. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci USA. 1991;88:1651-1655.
14. Yang Y, Nunes FA, Berenesi K, et al. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genetics. 1994;7:362-369